Disparities in breast cancer survival in the United States (2001-2009): Findings from the CONCORD-2 study

Cancer

Volumn 123, Issue , 2017, Pages 5100-5118

  Miller, Jacqueline W ^a   Smith, Judith Lee ^a   Ryerson, A Blythe ^a   Tucker, Thomas C ^b   Allemani, Claudia ^c  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

breast cancer; health disparities; population based survival; trends

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CONTROL; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; CONTROLLED STUDY; FEMALE; HEALTH CARE ACCESS; HEALTH CARE DISPARITY; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH PRACTITIONER; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PATIENT MONITORING; PRIORITY JOURNAL; TRIPLE NEGATIVE BREAST CANCER; UNITED STATES; VERY ELDERLY; AFRICAN AMERICAN; BREAST TUMOR; CAUCASIAN; EPIDEMIOLOGY; ETHNOLOGY; HEALTH DISPARITY; MIDDLE AGED; MORTALITY; PATHOLOGY; REGISTER; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; MIDDLE AGED; NEOPLASM STAGING; REGISTRIES; UNITED STATES; YOUNG ADULT;

EID: 85037621484     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.30988     Document Type: Article

References (45)

1. International Agency for Research on Cancer (IARC). GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012. Lyon, France: IARC; 2013. Available at: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx. Accessed April 12, 2016.
2. US Cancer Statistics Working Group. US Cancer Statistics: 1999-2013 Incidence and Mortality Web-based Report. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute; 2016. Available at: www.cdc.gov/uscs. Accessed December 9, 2016.
3. Ryerson AB, Eheman CR, Altekruse SF, et al. Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer. Cancer. 2016;122:1312-1337.
4. US Department of Health and Human Services (HHS). HHS Action Plan to Reduce Racial and Ethnic Health Disparities: A Nation Free of Disparities in Health and Health Care. Washington, DC: HHS; 2015. Available at: http://minorityhealth.hhs.gov/npa/files/plans/hhs/hhs_plan_complete.pdf. Accessed April 10, 2016.
5. Agency for Healthcare Research and Quality (AHRQ). National Healthcare Quality & Disparities Report Chartbooks. Rockville, MD: AHRQ, S Department of Health and Human Services; 2016. Available at: http://www.ahrq.gov/research/findings/nhqrdr/chartbooks/index.html. Accessed April 13, 2016.
6. Centers for Disease Control and Prevention (CDC). Strategies for reducing health disparities—selected CDC-sponsored interventions, United States, 2016. MMWR Suppl. 2016;65:1-69.
7. Centers for Disease Control and Prevention (CDC). About CDC's Office of Minority Health and Health Equity (OMHHE). Available at: https://www.cdc.gov/healthequity/about/index.html. Accessed April 13, 2016.
8. van Ravesteyn NT, Schechter CB, Near AM, et al. Race-specific impact of natural history, mammography screening, and adjuvant treatment on breast cancer mortality rates in the United States. Cancer Epidemiol Biomarkers Prev. 2011;20:112-122.
9. Richardson LC, Henley J, Miller J, Massetti G, Thomas CC. Patterns and trends in black-white differences in breast cancer incidence and mortality—United States, 1999-2013. MMWR Morb Moral Wkly Rep. 2016;65:1093-1098.
10. Howlader N, Noone AM, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2012. Bethesda, MD: National Cancer Institute; 2015. Available at: http://seer.cancer.gov/csr/1975_2012/. Accessed December 9, 2016.
11. Hunt BR, Whitman S, Hurlbert MS. Increasing black:white disparities in breast cancer mortality in the 50 largest cities in the United States. Cancer Epidemiol. 2014;38:118-123.
12. Ward E, Jemal A, Cokkinides V, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004;54:78-93.
13. Coleman M. Cancer survival: global surveillance will stimulate health policy and improve equity. Lancet. 2014;383:564-573.
14. Centers for Disease Control and Prevention (CDC). Vital signs: racial disparities in breast cancer severity—United States, 2005-2009. MMWR Morb Mortal Wkly Rep. 2012;61:922-926.
15. Coleman MP, Quaresma M, Berrino F, et al. Cancer survival in 5 continents: a worldwide population-based study (CONCORD). Lancet Oncol. 2008;9:730-756.
16. Allemani C Weir HK, Carreira H, et al. Global surveillance of cancer survival 1995-2009: analysis of individual data for 23,676,887 patient from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015;385:977-1010.
17. Allemani C, Weir HK, Carreira H, et al. CONCORD Working Group. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2.) Lancet. 2015;385:977-1010.
18. Fritz AG, Percy C, Jack A, et al, eds. International Classification of Diseases for Oncology (ICD-O). 3rd ed. Geneva, Switzerland: World Health Organization; 2000.
19. Young JL, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA. SEER Summary Staging Manual-2000: Codes and Coding Instructions. NIH Pub. No. 01-4969. Bethesda, MD: National Cancer Institute; 2001.
20. Surveillance, Epidemiology, and End Results (SEER) Program. Collaborative Stage. Bethesda, MD: National Cancer Institute; 2004. Available at: http://seer.cancer.gov/tools/collabstaging/. Accessed April 1, 2016.
21. Pohar Perme M, Stare J, Esteve J. On estimation in relative survival. Biometrics. 2012;68:113-120.
22. Rachet B, Maringe C, Woods LM, Ellis L, Spika D, Allemani C. Multivariable flexible modelling for estimating complete, smoothed life tables for sub-national populations [serial online]. BMC Public Health. 2015;15:1240.
23. Spika D, Bannon F, Bonaventure A, et al. Life tables for global surveillance of cancer survival (the CONCORD programme): data sources and methods [serial online]. BMC Cancer. 2017;17:159.
24. Corazziari I, Quinn MJ, Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer. 2004;40:2307-2316.
25. Quaresma M, Coleman MP, Rachet B. Funnel plots for population-based cancer survival: principles, methods and applications. Stat Med. 2014;33:1070-1080.
26. Allemani C, Harewood R, Johnson C, et al. Population-based cancer survival in the United States: data, quality control, and statistical methods. Cancer. 2017;123:4982-4993.
27. Behavioral Risk Factor Surveillance System (BRFSS). Prevalence and trends data. Atlanta, GA: Centers for Disease Control and Prevention; 2016. Available at: http://www.cdc.gov/brfss/brfssprevalence/. Accessed November 4, 2016.
28. Lund MJ, Brawley OP, Ward KC, Young JL, Gabram SS, Eley JW. Parity and disparity in first course treatment of invasive breast cancer. Breast Cancer Res Treat. 2008;109:545-557.
29. Taplin SH, Yabroff KR, Zapka J. A multilevel research perspective on cancer care delivery: the example of follow-up to an abnormal mammogram. Cancer Epidemiol Biomarkers Prev. 2012;21:1709-1715.
30. Stead LA, Lash TL, Sobieraj JE, et al. Triple negative breast cancers are increased in black women regardless of age or body mass index [serial online]. Breast Cancer Res. 2009;11:R18.
31. Brouckaert O, Wildiers H, Floris G, Neven P. Update on triple-negative breast cancer: prognosis and management strategies. Int J Womens Health. 2012;4:511-520.
32. Institute of Medicine (IOM). Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press; 2011. Available at: http://nationalacademies.org/hmd/Reports/2011/Breast-Cancer-and-the-Environment-A-Life-Course-Approach.aspx. Accessed June, 21, 2016.
33. Division of Cancer Prevention and Control, Centers for Disease Control and Prevention. What can I do to reduce my risk of breast cancer? Available at: http://www.cdc.gov/cancer/breast/basic_info/prevention.htm. Accessed June 20, 2016.
34. American Cancer Society. Lifestyle related risk factors for breast cancer. Available at: http://www.cancer.org/cancer/breastcancer/moreinformation/breastcancerearlydetection/breast-cancer-early-detection-risk-lifestyle-related. Accessed June 20, 2016.
35. Forman MR, Winn DM, Collman GW, Rizzo J, Birnbaum LS. Environmental exposures, breast development and cancer risk: through the looking glass of breast cancer prevention. Reprod Toxicol. 2015;54:6-10.
36. Tammemagi CM, Nerenz D, Neslund-Dudas C, Feldkamp C, Nathanson D. Comorbidity and survival disparities among black and white patients with breast cancer. JAMA. 2005;294:1765-1772.
37. Zimmerman RK, Tabbarah M, Nowalk MP, et al. Racial differences in beliefs about genetic screening among patients at inner-city neighborhood health centers. J Natl Med Assoc. 2006;98:370-377.
38. Armstrong K, Micco E, Carney A, Stopfer J, Putt M. Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. JAMA. 2005;293:1729-1736.
39. Peters N, Rose A, Armstrong K. The association between race and attitudes about predictive genetic testing. Cancer Epidemiol Biomarkers Prev. 2004;13:361-365.
40. Wheeler SB, Reeder-Hayes KE, Carey LA. Disparities in breast cancer treatment and outcomes: biological, social, and health system determinants and opportunities for research. Oncologist. 2013;18:986-993.
41. Ward E, Halpern M, Schrag N, et al. Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin. 2008;58:9-31.
42. Hershman D, McBride R, Jacobson JS, et al. Racial disparities in treatment and survival among women with early-stage breast cancer. J Clin Oncol. 2005;23:6639-6646.
43. Dignam JJ. Differences in breast cancer prognosis among African-American and Caucasian women. CA Cancer J Clin. 2000;50:50-64.
44. Suppl to: Allemani C, Weir HK, Carreira H, et al. and the CONCORD Working Group. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 2014; published online Nov 26. Available at: http://www.thelancet.com/journals/lancet/article/PIIS0140-673662038-9/supplemental. Accessed June 28, 2016.
45. White MC, Babcock F, Hayes NS, et al. The history and use of cancer registry data and public health cancer control programs in the United States. Cancer. 2017;123:4969-4976.